Rios Miguel De Los - Net Worth and Insider Trading

Rios Miguel De Los Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rios Miguel De Los owns 1 companies in total, including Eloxx Pharmaceuticals Inc (ELOX) .

Click here to see the complete history of Rios Miguel De Los’s form 4 insider trades.

Insider Ownership Summary of Rios Miguel De Los

Ticker Comapny Transaction Date Type of Owner
ELOX Eloxx Pharmaceuticals Inc 2014-05-16 VP - Research

Rios Miguel De Los Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rios Miguel De Los Ownership Network

Ownership Network List of Rios Miguel De Los

No Data

Ownership Network Relation of Rios Miguel De Los

Insider Network Chart

Rios Miguel De Los Owned Company Details

What does Eloxx Pharmaceuticals Inc do?

Who are the key executives at Eloxx Pharmaceuticals Inc?

Rios Miguel De Los is the VP - Research of Eloxx Pharmaceuticals Inc. Other key executives at Eloxx Pharmaceuticals Inc include director & PRESIDENT AND CEO Sumit Aggarwal , HEAD OF R&D Vijay Modur , and Chief Financial Officer Daniel E. Geffken .

Eloxx Pharmaceuticals Inc (ELOX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eloxx Pharmaceuticals Inc (ELOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eloxx Pharmaceuticals Inc (ELOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eloxx Pharmaceuticals Inc (ELOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eloxx Pharmaceuticals Inc Insider Transactions

No Available Data

Rios Miguel De Los Mailing Address

Above is the net worth, insider trading, and ownership report for Rios Miguel De Los. You might contact Rios Miguel De Los via mailing address: 11099 N. Torrey Pines Rd., Ste 230, La Jolla Ca 92037.

Discussions on Rios Miguel De Los

No discussions yet.